Antimicrobial Peptide Resistance Mechanisms

Overview

Antimicrobial peptides (AMPs) are ubiquitous components of innate immunity that exert broad-spectrum bactericidal activity primarily through electrostatic interaction with negatively charged bacterial membranes. The multivalent, non-specific mechanism of AMP action was historically considered to impose a high barrier to resistance development. However, accumulating evidence demonstrates that bacteria employ multiple, often overlapping strategies to evade AMP-mediated killing, including modification of target membranes, enzymatic degradation, active efflux, and intracellular sequestration.

Membrane Modification

Lipopolysaccharide (LPS) Remodeling

Gram-negative bacteria modify their outer membrane LPS to reduce net negative charge, thereby decreasing electrostatic attraction to cationic AMPs. The archetypal mechanism involves addition of 4-amino-4-deoxy-L-arabinose (Ara4N) to lipid A by the PhoPQ-regulated ArnT transferase, neutralizing the phosphate groups of LPS. Similarly, modification of lipid A phosphates with phosphoethanolamine (PEtN) by the EptA methyltransferase reduces AMP binding affinity. In Salmonella and Escherichia coli, the PmrAB two-component system coordinates these modifications in response to environmental stimuli including low magnesium, acidic pH, and direct AMP exposure.

Phospholipid Asymmetry and Carotenoid Deposition

Gram-positive bacteria alter membrane phospholipid composition to counter AMP insertion. Staphylococcus aureus increases lysyl-phosphatidylglycerol (L-PG) content through the MprF flippase, reducing the availability of anionic phosphatidylglycerol at the outer leaflet. The crtM gene encodes staphyloxanthin synthase, producing the carotenoid pigment staphyloxanthin that rigidifies the membrane bilayer and physically impedes AMP insertion into the lipid acyl chain region.

Protease-Mediated Degradation

Bacteria secrete or surface-localize proteases that degrade AMPs before they reach their membrane targets. The outer membrane protease OmpT of E. coli cleaves cationic AMPs including LL-37 and polymyxins at exposed basic residues. S. aureus secretes aureolysin, a zinc-dependent metalloproteinase that inactivates human cathelicidin LL-37 and the AMP dermcidin. Additionally, the Pseudomonas aeruginosa elastase LasB degrades multiple host defense peptides, contributing to immune evasion during chronic infection. Protease expression is frequently co-regulated with AMP resistance through conserved two-component signal transduction pathways.

Efflux-Mediated Export

Active efflux of AMPs across the inner membrane represents a less characterized but clinically significant resistance mechanism. The MtrCDE efflux pump system of Neisseria gonorrhoeae exports hydrophobic antimicrobial compounds including LL-37 and human beta-defensins. In Campylobacter jejuni, the CmeAB and CmeDEF multidrug efflux systems contribute to resistance against host-derived AMPs encountered in the intestinal mucus layer. These efflux systems typically belong to the resistance-nodulation-division (RND) or multidrug and toxic compound extrusion (MATE) transporter families.

Intracellular Sequestration

A newly appreciated mechanism involves cytoplasmic sequestration of internalized AMPs away from their membrane targets. S. aureus employs the MprF protein to both modify membrane phospholipids and sequester cationic AMPs at the membrane-cytoplasm interface. The ABC transporter FtsH contributes to AMP resistance by degrading membrane-associated peptides. In mycobacteria, the DrrAB efflux system exportsAMPs from the periplasm, while the SapABCDEF transporter of Salmonella maintains periplasmic AMP concentrations below lethal thresholds.

Conclusion

Bacterial AMP resistance mechanisms are diverse, multilayered, and frequently subject to horizontal gene transfer, raising concerns about the emergence of pan-resistant pathogens. Understanding these mechanisms is essential for the rational design of AMP-based therapeutics with enhanced resistance profiles and for informing combination strategies that circumvent existing evasion pathways.